The tweet was deleted by the author.
But we saved everything 🙂.
Neurogene Inc. announced two key leadership moves, naming Christy Shafer as Chief Commercial Officer and appointing Christine Mikail to its Board of Directors in addition to her existing roles as President and Chief Financial Officer.
The company stated that these appointments are aimed at strengthening its executive leadership as it advances its strategic initiatives.
Neurogene recently provided a corporate update on its 2025 financial results and developments for its NGN-401 program. The company highlighted ongoing research and development efforts in its latest disclosure. NGN-401 remains a focus as Neurogene advances its strategic plans.